Inhibition of Gap Junctions Sensitizes Primary Glioblastoma Cells for Temozolomide

Cancers - Switzerland
doi 10.3390/cancers11060858
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Quercetin Sensitizes Human Glioblastoma Cells to Temozolomide in Vitro via Inhibition of Hsp27

Acta Pharmacologica Sinica
MedicinePharmacology
2014English

Momelotinib Sensitizes Glioblastoma Cells to Temozolomide by Enhancement of Autophagy via JAK2/STAT3 Inhibition

Oncology Reports
MedicineCancer ResearchOncology
2019English

RNA Interference Targeting Aurora-A Sensitizes Glioblastoma Cells to Temozolomide Chemotherapy

Oncology Letters
Cancer ResearchOncology
2016English

Casein Kinase 2 Inhibition Sensitizes Medulloblastoma to Temozolomide

Oncogene
Cancer ResearchGeneticsMolecular Biology
2019English

Regulation of the Oxidative Balance With Coenzyme Q10 Sensitizes Human Glioblastoma Cells to Radiation and Temozolomide

Radiotherapy and Oncology
Nuclear MedicineOncologyRadiologyHematologyImaging
2018English

Regulation of Integrated Stress Response Sensitizes U87MG Glioblastoma Cells to Temozolomide Through the Mitochondrial Apoptosis Pathway

Anatomical Record
EvolutionEcologySystematicsAnatomyHistologyBehaviorBiotechnology
2018English

Epigenetic Preconditioning With Decitabine Sensitizes Glioblastoma to Temozolomide via Induction of MLH1

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2020English

Bone Morphogenetic Protein 7 Sensitizes O6-Methylguanine Methyltransferase Expressing-Glioblastoma Stem Cells to Clinically Relevant Dose of Temozolomide

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2015English

Temozolomide Nanoparticles for Targeted Glioblastoma Therapy

ACS Applied Materials & Interfaces
MedicineMaterials ScienceNanotechnologyNanoscience
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy